Faculty profile

Murray Baron

ResearcherRheumatologyMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses may be missing. Find their university profile.

Murray Baron

Researcher

Rheumatology

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
50 publications in the last five years, latest in 2026.
Senior (last) author on 9 recent papers, a sign of leading a research group.
Principal investigator on 8 research grants (8 CIHR), most recently in 2018.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

225

Publications

3,358

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Systemic Sclerosis Immunology Scleroderma Fibrosis Epigenetics Rheumatoid Arthritis Systemic Lupus Erythematosus Autologous Hematopoetic Stem Cell Transplant

Latest papers

Associations with, and predictors of, progression in systemic sclerosis-related interstitial lung disease: a scoping literature review.
European respiratory review : an official journal of the European Respiratory Society · 2026 · senior author
Outdated Frameworks, Missed Opportunities: A Call for Establishing Classification Criteria for Patients with Sarcoidosis.
Rheumatology and therapy · 2026 · senior author
Scleroderma Clinical Trials Consortium (SCTC) outcome instruments for evaluation of systemic sclerosis.
Journal of scleroderma and related disorders · 2026 · senior author

All 225 publications

Latest funding

MUC16 (CA125) mutations promote fibrosis and autoimmunity in systemic sclerosis
CIHR · 2023 · Co-investigator
$730,576
Randomized Double-Blind Placebo-Controlled Clinical Trial to Assess the Efficacy of Mycophenolate Mofetil in Subclinical Interstitial Lung Disease Associated with Systemic Sclerosis: a Feasibility Study
CIHR · 2022 · Co-investigator
$346,640
MUC16 (CA125) mutations promote fibrosis and autoimmunity in systemic sclerosis
CIHR · 2022 · Co-investigator
$100,000

All 17 grants and awards

From the 150 most recent of 225 publications.

Associations with, and predictors of, progression in systemic sclerosis-related interstitial lung disease: a scoping literature review.

Morrisroe K, Baron M

European respiratory review : an official journal of the European Respiratory Society2026Senior author

DOI: 10.1183/16000617.0273-2024 PMID: 41534888

Outdated Frameworks, Missed Opportunities: A Call for Establishing Classification Criteria for Patients with Sarcoidosis.

Sweiss NJ, Dominati A, McGowan M, Shivas T, Ladouceur A, Rubinstein I, Baron M

Rheumatology and therapy2026Senior author

DOI: 10.1007/s40744-026-00838-1 PMID: 41882446

Scleroderma Clinical Trials Consortium (SCTC) outcome instruments for evaluation of systemic sclerosis.

Valenzuela A, Chung L, Pauling JD, Domsic R, Saketkoo L, Fligelstone K, Russell AM, Khanna D, Frech T, Ross L, Nikpour M, Denton C, Baron M

Journal of scleroderma and related disorders2026Senior author

DOI: 10.1136/jsrd-2026-000009 PMID: 42256631

Non-contiguous computed tomography lung scans can be manipulated to permit artificial intelligence analyses for interstitial lung disease in systemic sclerosis.

Baron M, Nguyen Q, Kovacina B, Van Eeden C, Langs G

Biology methods & protocols2026First author

DOI: 10.1093/biomethods/bpag024 PMID: 42238221

Proportions of patients meeting definitions for progressive disease or improvement should be included in clinical trials for systemic sclerosis interstitial lung disease.

Morrisroe K, Tashkin D, Baron M

Arthritis research & therapy2026Senior author

DOI: 10.1186/s13075-026-03803-z PMID: 41981638

Scleroderma clinical trials consortium classification criteria for systemic sclerosis heart involvement.

Ross L, Burns AT, La Gerche A, Hansen D, Coghlan JG, Stevens W, Prior D, Pham A, McKelvie P, Bellocchi C, Braun Moscovici Y, Bruni C, Carreira P, Frech T, Hoa S, Hudson M, Hsu V, Hsiu Ling Low A, Matucci-Cerinic M, Medina Fonseca B, Ng SA, Rodriguez Reyna T, Sahhar J, Talaat M, Proudman S, Vacca A, Baron M, Nikpour M, and the SCTC Cardiac Working Group

Rheumatology (Oxford, England)2026

DOI: 10.1093/rheumatology/keag109 PMID: 41758916

Real-World Safety and Effectiveness of JAK Inhibitors in Systemic Sclerosis: A Propensity-Matched Study From the EUSTAR Cohort.

Di Donato S, Truchetet ME, Minerba M, Distler O, Alegre Sancho JJ, Braun-Moscovici Y, Bergmann C, Sfikakis P, de Vries-Bouwstra JK, Baron M, Bellando-Randone S, Dagna L, Denton CP, Vonk MC, Smith V, Castellvi I, Riemekasten G, Balanescu A, Kuwana M, De Santis M, Solanki K, Batalov A, Mukuchyan V, Matucci-Cerinic M, Allanore Y, Del Galdo F, Hughes M, EUSTAR Collaborators

Arthritis care & research2026

DOI: 10.1002/acr.80100 PMID: 42294821

Points to consider for reporting digital ulcers in systemic sclerosis interventional studies: An initiative from the world Scleroderma Foundation digital ulcer ad hoc committee.

Campochiaro C, Maltez N, Suliman Y, Alunno A, Alcacer-Pitarch B, Allanore Y, Baron M, Chung L, Del Galdo F, Denton CP, Distler O, Furst D, Galetti I, Giuggioli D, Khanna D, Krieg T, Moinzadeh P, Kuwana M, Matucci-Cerinic M, Pope J, Hughes M

Autoimmunity reviews2026

DOI: 10.1016/j.autrev.2026.104010 PMID: 41740914

Distinct Systemic Sclerosis Phenotypes Related to Ethnicity: An Opportunity to Personalize Care?

Goulet D, Guertin C, Larché M, Ferdinand I, Hudson M, Choi MY, Osman M, Pope J, Thorne C, Baron M

Arthritis Care and Research20261 citations

DOI: 10.1002/acr.80098

The minimal clinically important difference of the scleroderma clinical trials consortium damage index.

Baron M, Hansen D, Proudman S, Stevens W, Wang M, Nikpour M

Journal of scleroderma and related disorders2025First author

DOI: 10.1177/23971983251327808 PMID: 40160310

Something wrong or missing on this profile? Suggest a correction

Murray Baron

Research

Latest papers

Latest funding

Associations with, and predictors of, progression in systemic sclerosis-related interstitial lung disease: a scoping literature review.

Outdated Frameworks, Missed Opportunities: A Call for Establishing Classification Criteria for Patients with Sarcoidosis.

Scleroderma Clinical Trials Consortium (SCTC) outcome instruments for evaluation of systemic sclerosis.

Non-contiguous computed tomography lung scans can be manipulated to permit artificial intelligence analyses for interstitial lung disease in systemic sclerosis.

Proportions of patients meeting definitions for progressive disease or improvement should be included in clinical trials for systemic sclerosis interstitial lung disease.

Scleroderma clinical trials consortium classification criteria for systemic sclerosis heart involvement.

Real-World Safety and Effectiveness of JAK Inhibitors in Systemic Sclerosis: A Propensity-Matched Study From the EUSTAR Cohort.

Points to consider for reporting digital ulcers in systemic sclerosis interventional studies: An initiative from the world Scleroderma Foundation digital ulcer ad hoc committee.

Distinct Systemic Sclerosis Phenotypes Related to Ethnicity: An Opportunity to Personalize Care?

The minimal clinically important difference of the scleroderma clinical trials consortium damage index.

Frequent collaborators

Marie Hudson

Nader Khalidi

Russell Steele

Margaret Larche

Janet Pope

Sasha Bernatsky

Sasha Bernatsky

Linda Kwakkenbos

Nancy Maltez

Sabrina Hoa

Sabrina Hoa

Elena Netchiporouk

Elham Rahme

Danielle Rice

Phyllis Zelkowitz

Mohammed Osman

Andrea Benedetti

Ghassan El-Baalbaki

Debora Matthews

Debora Matthews

Tarek El-Sayegh

Ian Shrier

Michal Abrahamowicz

Carter Thorne

Evelyne Vinet

Evelyne Vinet

Thao Huynh

Luc Mouthon

Ines Colmegna

Mohit Kapoor

Tomoko Takano

Peter Tugwell

Brett Thombs

Andrew Chow

Mats Junek

Johanne Martel-Pelletier

Jiangping Wu